Autism causes

Jump to navigation Jump to search

Autism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autism causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autism causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autism causes

CDC on Autism causes

Autism causes in the news

Blogs on Autism causes

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Autism causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Autism and autism spectrum disorders are complex neurodevelopmental disorders. Many causes of autism have been proposed, but its theory of causation is still incomplete. Heritability contributes about 90% of the risk of a child developing autism, but the genetics of autism are complex and typically it is unclear which genes are responsible. In rare cases, autism is strongly associated with agents that cause birth defects. Many other causes have been proposed, such as exposure of children to vaccines; these proposals are controversial and the vaccine hypotheses have no convincing scientific evidence.

Causes

The most important causative factor for autism is genetic abnormality. Other causes include prenatal and post natal infections.

Genetics

  • Genetic factors are the most significant cause for autism spectrum disorders.
  • Early studies of twins estimated heritability to be over 90% to develop autism.[1][2]
  • For adult siblings the risk for having one or more features of the broader autism phenotype might be as high as 30%.[3][4][1][5][6]
Deletion (1), duplication (2) and inversion (3) are all chromosome abnormalities that have been implicated in autism.[7]
  • The genetics of autism is complex.[1]
  • Typically, autism cannot be traced to a Mendelian (single-gene) mutation or to single chromosome abnormalities such as Angelman syndrome or fragile X syndrome, and none of the genetic syndromes associated with ASDs has been shown to selectively cause ASD.
  • There may be significant interactions among mutations in several genes, or between the environment and mutated genes.
  • Numerous candidate genes have been located, with only small effects attributable to any particular gene.
  • The large number of autistic individuals with unaffected family members may result from copy number variations (CNVs)—spontaneous deletions or duplications in genetic material during meiosis.[8]
  • Hence, a substantial fraction of autism may be highly heritable but not inherited: that is, the mutation that causes the autism is not present in the parental genome.[7]
  • Linkage analysis has been inconclusive; many association analyses have had inadequate power.[2]
  • More than one gene may be implicated, different genes may be involved in different individuals, and the genes may interact with each other or with environmental factors.[9]
  • Several candidate genes have been located, but the mutations that increase autism risk have not been identified for most candidate genes.[10][4]

22q13 Deletion Syndrome

The deletion of the tip of the chromosome 22 is related to autism, moderate to severe developmental delay, and mental retardation. It is known as 22q13 deletion syndrome or Phelan-McDermid syndrome.

The deletion affects the terminal region of the long arm of chromosome 22 (the paternal chromosome in 75% of cases), from 22q13.3 to 22qter. Although the deletion is most typically a result of a de novo mutation, there is an inherited form resulting from familial chromosomal translocations involving the 22 chromosome. In the de novo form, the size of the deletion is variable and can go from 130kbp (130,000 base pairs) to 9Mbp (9,000,000 base pairs). While some clinical signs correlate with the size of the deletion, the main traits of the syndrome appear to be independent of the deletion size, and only related to the presence of the SHANK3 gene [11]. The haploinsufficiency of SHANK3 is thought to be the responsible for the neurological deficits of the syndrome (Wilson et al., 2003).

The proteins encoded by the SHANK genes assemble glutamate receptors with their intracellular signaling apparatus and cytoskeleton at the postsynaptic density. They are important for the formation and stabilisation of synapses:

  • Experimentally induced expression of SHANK3 has been shown to be sufficient to induce functional dendritic spines in aspiny cerebellar neurons (Roussignol et al., 2005).
  • Neural network activity up- or down regulates large groups of postsynaptic proteins through ubiquitin-mediated protein degradation. SHANK proteins were identified as one of the few postsynaptic density proteins that can be degraded by ubiquitination (Waites et al., 2005)

In 2006, a group lead by Thomas Bourgeron from the Pasteur Institute in France, found anomalies of the 22q13 locus in five children with diagnosis of autism and Asperger syndrome. While the absence of the SHANK3 gene was found in children with the typical characteristics of the Phelan-McDermid syndrome, its duplication was found in one child diagnosed with Asperger syndrome,[12][13] a type of high-functioning autism.

Van Bokhoven et al. (1997) have also assigned the WNT7B gene to 22q13 [14]. Wnt7b acts through Dvl1 to the regulation of dendritic development. Rosso et al. (2005) found that its overexpression resulted in increased dendritic branching in cultured mouse hippocampal neurons. Knockout mice for Dvl1 are viable, fertile and structurally normal, but show reduced social interaction and abnormal sleeping patterns (Lijam et al, 1997)

Incidence

The incidence of the 22q13 deletion syndrome is uncertain. The advanced genetic technique essential for diagnosis, fluorescent in situ hybridization (FISH), has only been available since 1998, and currently requires specialized laboratory facilities. Current thinking is that 22q13 deletion syndrome remains largely under-diagnosed, and may be one of the principal causes of idiopathic mental retardation (Manning and al. 2004).

Heritability of Autism

The heritability of autism is a source of controversy about the causes of autism. Though it is agreed that there is a genetic susceptibility to autism, disagreements arise over the whether the condition is genetically determined and therefore inevitable, or is triggered by factors in the environment. The controversy is made more difficult by the broad spectrum of phenotypes labeled "autism", ranging from near total disability to mild social difficulties.

Identical twin studies put autism's heritability in a range between 0.36 and 0.957, with concordance for a broader phenotype usually found at the higher end of the range.[15] Autism concordance in siblings and fraternal twins is anywhere between 0 and 23.5%. This is more likely 2–4% for classic autism and 10–20% for a broader spectrum. Assuming a general-population prevalence of 0.1%, the risk of classic autism in siblings is 20- to 40-fold that of the general population.

Researchers usually note that autism is among the most heritable of all neurological conditions, even among the more than 90% of cases not associated with known genetic diseases such as fragile X syndrome or muscular dystrophy.[16][17]

Twin Studies

Twin studies are a helpful tool in determining the heritability of disorders and low-prevalence human traits in general. They involve determining concordance of characteristics between identical (monozygotic or MZ) twins and between fraternal (dizygotic or DZ) twins. Possible problems of twin studies are: (1) errors in diagnosis of monozygocity, and (2) the assumption that social environment sharing by DZ twins is equivalent to that of MZ twins.

A condition that is environmentally caused without genetic involvement would yield a concordance for MZ twins equal to the concordance found for DZ twins. In contrast, a condition that is completely genetic in origin would theoretically yield a concordance of 100% for MZ pairs and usually much less for DZ pairs depending on factors such as the number of genes involved and assortative mating. An example of a condition that appears to have very little if any genetic influence is irritable bowel syndrome (IBS), with a concordance of 28% vs. 27% for MZ and DZ pairs respectively.[18] An example of a human characteristics that is extremely heritable is eye color, with a concordance of 98% for MZ pairs and 7–49% for DZ pairs depending on age.[19] Notable twin studies have attempted to shed light on the heritability of autism.

A small scale study in 1977 was the first of its kind to look into the heritability of autism. It involved 10 DZ and 11 MZ pairs in which at least one twin in each pair showed infantile autism. It found a concordance of 36% in MZ twins compared to 0% for DZ twins. Concordance of "cognitive abnormalities" was 82% in MZ pairs and 10% for DZ pairs. In 12 of the 17 pairs discordant for autism, a biological hazard was believed to be associated with the condition.[20]

A 1979 case report discussed a pair of identical twins concordant for autism. The twins developed similarly until the age of 4, when one of them spontaneously improved. The other twin, who had suffered infrequent seizures, remained autistic. The report noted that genetic factors were not "all important" in the development of the twins.[21]

In 1985, a study of twins enrolled with the UCLA Registry for Genetic Studies found a concordance of 95.7% for autism in 23 pairs of MZ twins, and 23.5% for 17 DZ twins.[22]

In a 1989 study, Nordic countries were screened for cases of autism. Eleven pairs of MZ twins and 10 of DZ twins were examined. Concordance of autism was found to be 91% in MZ and 0% in DZ pairs. The concordances for "cognitive disorder" were 91% and 30% respectively. In most of the pairs discordant for autism, the autistic twin had more perinatal stress.[23]

A British twin sample was reexamined in 1995 and a 60% concordance was found for autism in MZ twins vs. 0% concordance for DZ. It also found 92% concordance for a broader spectrum in MZ vs. 10% for DZ. The study concluded that "obstetric hazards usually appear to be consequences of genetically influenced abnormal development, rather than independent aetiological factors."[24]

A 1999 study looked at social cognitive skills in general-population children and adolescents. It found "poorer social cognition in males", and a heritability of 0.68 with higher genetic influence in younger twins.[25]

In 2000, a study looked at reciprocal social behavior in general-population identical twins. It found a concordance of 73% for MZ, i.e. "highly heritable", and 37% for DZ pairs.[26]

A 2004 study looked at 16 MZ twins and found a concordance of 43.75% for "strictly defined autism". Neuroanatomical differences (discordant cerebellar white and grey matter volumes) between discordant twins were found. The abstract notes that in previous studies 75% of the non-autistic twins displayed the broader phenotype.[27]

Another 2004 study examined whether the characteristic symptoms of autism (impaired social interaction, communication deficits, and repetitive behaviors) show decreased variance of symptoms among monozygotic twins compared to siblings in a sample of 16 families. The study demonstrated significant aggregation of symptoms in twins. It also concluded that "the levels of clinical features seen in autism may be a result of mainly independent genetic traits."[28]

An English twin study in 2006 found high heritability for autistic traits in a large group of 3,400 pairs of twins.[29]

One critic of the pre-2006 twin studies said that they were too small and their results can be plausibly explained on non-genetic grounds.[30]

Sibling Studies

The importance of sibling studies lies in contrasting their results to those of fraternal (DZ) twin studies, plus their sample sizes can be much larger. Environment sharing by siblings is presumably different enough to that of DZ twins to shed some light on the magnitude of environmental influence. This should even be true to some extent regarding the prenatal environment. Unfortunately DZ twin study findings have yielded a very large range of variance and are error prone because of the apparent low concordance and the fact that they typically look at a small number of DZ pairs. For example, in studies involving 10 DZ pairs, a concordance below 10% would be impossible to determine precisely.

A study of 99 autistic probands which found a 2.9% concordance for autism in siblings, and between 12.4% and 20.4% concordance for a "lesser variant" of autism.[31]

A study of 31 siblings of autistic children, 32 siblings of children with developmental delay, and 32 controls. It found that the siblings of autistic children, as a group, "showed superior spatial and verbal span, but a greater than expected number performed poorly on the set-shifting, planning, and verbal fluency tasks."[32]

A 2005 Danish study looked at "data from the Danish Psychiatric Central Register and the Danish Civil Registration System to study some risk factors of autism, including place of birth, parental place of birth, parental age, family history of psychiatric disorders, and paternal identity." It found an overall prevalence rate of roughly 0.08%. Prevalence of autism in siblings of autistic children was found to be 1.76%. Prevalence of autism among siblings of children with Asperger's syndrome or PDD was found to be 1.04%. The risk was twice as high if the mother had been diagnosed with a psychiatric disorder. The study also found that "the risk of autism was associated with increasing degree of urbanisation of the child's place of birth and with increasing paternal, but not maternal, age."[33]

A study in 2007 looked at a database containing pedigrees of 86 families with two or more autistic children and found that 42 of the third-born male children showed autistic symptoms, suggesting that parents had a 50% chance of passing on a mutation to their offspring. The mathematical models suggest that about 50% of autistic cases are caused by spontaneous mutations. The simplest model was to divide parents into two risk classes depending on whether the parent carries a pre-existing mutation that causes autism; it suggested that about a quarter of autistic children have inherited a copy number variation from their parents.[34]

Other Family Studies

A 1994 looked at the personalities of parents of autistic children, using parents of children with Down's syndrome as controls. Using standardized tests it was found that parents of autistic children were "more aloof, untactful and unresponsive."[35]

A 1997 study found higher rates of social and communication deficits and stereotyped behaviors in families with multiple-incidence autism.[36]

Autism was found to occur more often in families of physicists, engineers and scientists. Other studies have yielded similar results.[37][38] Findings of this nature have led to the coinage of the term "geek syndrome".[39]

A 2001 study of brothers and parents of autistic boys looked into the phenotype in terms of one current cognitive theory of autism. The study raised the possibility that the broader autism phenotype may include a "cognitive style" (weak central coherence) that can confer information-processing advantages.[40]

A study in 2005 showed a positive correlation between repetitive behaviors in autistic individuals and obsessive-compulsive behaviors in parents.[41] Another 2005 study focused on sub-threashold autistic traits in the general population. It found that correlation for social impairment or competence between parents and their children and between spouses is about 0.4.[42]

A 2005 report examined the family psychiatric history of 58 subjects with Asperger's syndrome (AS) diagnosed according to DSM-IV criteria. Three (5%) had first-degree relatives with AS. Nine (19%) had a family history of schizophrenia. Thirty five (60%) had a family history of depression. Out of 64 siblings, 4 (6.25%) were diagnosed with AS.[43]

Twinning Risk

It has been suggested that the twinning process itself is a risk factor in the development of autism, presumably due to perinatal factors.[44] However, three large-scale epidemiological studies have refuted this idea.[45][46]

Phenocopies

Evidence has mounted indicating that clinical pictures that look like autism (phenocopies) may not be due to the same genetic liability. Examples are congenital blindness,[47] profound institutional privation,[48][49] and a number of conditions related to mental retardation.[50] Fragile-X syndrome, Rett syndrome and tuberous sclerosis are well-known causes of autism-like symptoms.

Mendelian

The original Mendelian model tried to explain observations using distinct genes existing in clearly dominant or recessive alleles. That would imply a recessive "autism gene" inherited from each of the parents. This kind of model is clearly too simple:

  • It indicates that a sibling of an autistic individual should have 25% risk of having the autistic genotype, which is inconsistent with fraternal twin and sibling study results.
  • It would require several characteristic features of autism to be caused by a single allele at a single locus.

Further considerations for the 'autism gene model' of also show contradictory implications:

  • (a) only a small number of cases can be clearly linked to a possible genetic cause and these are often allele deletions;
  • (b) the majority of patients with autism do not marry and do not have offspring which should result in a decreased incidence of the presumed gene in the general population.
  • (c) the incidence of autism in the population has been increasing instead, making the likelihood of a single genetic cause extremely remote.

Mendel's later work and work based on it introduced polygenic inheritance, but taking into account linkage of genes required understanding where they were located - elucidating the role of the chromosomes

Multigene

Reduced risk to relatives of probands and identical/fraternal twin ratios indicate that a multigene model is more likely to account for the autistic genotype. That is, at least two alleles would be involved, and most likely three to five. Researchers have suggested models of 15 and even up to 100 genes.

The fraternal twin results found by Ritvo et al (1985)[22] and the broader phenotype results of Bolton et al (1994)[31] suggest that a 2-gene model is plausible. Kolevzon et al (2004) proposed that the 3 characteristic symptoms of autism may be the result of 3 different alleles.[citation needed] Data supports the multiple-locus hypothesis and also that a 3-loci model is the best fit.[51] Risch et al (1999) found results most compatible with a large number of loci (>= 15).[52]

Given the significant prevalence of autism, perhaps 0.1% for classic autism and at least 0.6% for a broader spectrum, a multigene model has important implications. Since intelligence appears to be independent of the recognized characteristic symptoms of autism (and the diagnostic criteria) it is likely that many individuals are very autistic yet highly functional, allowing them to escape a diagnosis altogether. So the prevalence of the autistic genotype may be considerably higher than thought. And if multiple alleles are part of the genotype, then each allele must have relatively high prevalence in the general population.

Two Family Types

In this model most families fall into two types: in the majority, sons have a low risk of autism, but in a small minority their risk is near 50%. In the low-risk families, sporadic autism is mainly caused by spontaneous mutation with poor penetrance in daughters and high penetrance in sons. The high-risk families come from (mostly female) children who carry a new causative mutation but are unaffected and transmit the dominant mutation to grandchildren.[34]

Epigenetic

A number of epigenetic models of autism have been proposed as have several genetic imprinting models.[53][54] These are suggested by the occurrence of autism in individuals with fragile X syndrome, which arises from epigenetic mutations, and with Rett syndrome, which involves epigenetic regulatory factors. An epigenetic model would help explain why standard genetic screening strategies have so much difficulty with autism.[55]

Candidate Gene Loci

A number of alleles have been shown to have strong linkage to the autism phenotype. In many cases the findings are inconclusive, with some studies showing no linkage. Alleles linked so far strongly support the assertion that there is a large number of genotypes that are manifested as the autism phenotype. At least some of the alleles associated with autism are fairly prevalent in the general population, which indicates they are not rare pathogenic mutations. This also presents some challenges in identifying all the rare allele combinations involved in the etiology of autism.

17q11.2 region, SERT (SLC6A4) locus – This gene locus has been associated with rigid-compulsive behaviors. Notably, it has also been associated with depression but only as a result of social adversity, although other studies have found no link.[56] Significant linkage in families with only affected males has been shown.[57][58] Researchers have also suggested that the gene contributes to hyperserotonemia.[59]

GABA receptor subunit genesGABA is the primary inhibitory neurotransmitter of the human brain. Ma et al (2005) concluded that GABRA4 is involved in the etiology of autism, and that it potentially increases autism risk through interaction with GABRB1.[60] The GABRB3 gene has been associated with savant skills.[61] The GABRB3 gene deficient mouse has been proposed as a model of ASD.[62]

Engrailed 2 (EN2) – Engrailed 2 is believed to be associated with cerebellar development. Benayed et al (2005) estimate that this gene contributes to as many as 40% of ASD cases, about twice the prevalence of the general population.[63] But at least one study has found no association.[64]

3q25-27 region – A number of studies have shown a significant linkage of autism and Asperger's syndrome with this locus.[65][66] The most prominent markers are in the vicinity of D3S3715 and D3S3037.[67]

7q21-q36 region, REELIN (RELN) – In adults, Reelin glycoprotein is believed to be involved in memory formation, neurotransmission, and synaptic plasticity. A number of studies have shown an association between the REELIN gene and autism,[68][69] but a couple of studies were unable to duplicate linkage findings.[70]

SLC25A12 – This gene, located in chromosome 2q31, encodes the mitochondrial aspartate/glutamate carrier (AGC1). It has been found to have a significant linkage to autism in some studies,[71][72] but linkage was not replicated in others,[73] and a 2007 study found no compelling evidence of an association of any mitochondrial haplogroup in autism.[74]

HOXA1 and HOXB1 – A link has been found between HOX genes and the development of the embryonic brain stem. In particular, two genes, HOXA1 and HOXB1, in transgenic 'knockout' mice, engineered so that these genes were absent from the genomes of the mice in question, exhibited very specific brain stem developmental differences from the norm, which were directly comparable to the brain stem differences discovered in a human brain stem originating from a diagnosed autistic patient.[75]

Conciatori et al (2004) found an association of HOXA1 with increased head circumference.[76] A number of studies have found no association with autism.[77][78][79] The possibility remains that single allelic variants of the HOXA1 gene are insufficient alone to trigger the developmental events in the embryo now associated with autistic spectrum conditions. Tischfield et al published a paper which suggests that because HOXA1 is implicated in a wide range of developmental mechanisms, a model involving multiple allelic variants of HOXA1 in particular may provide useful insights into the heritability mechanisms involved.[80] Additionally, Ingram et al alighted upon additional possibilities in this arena.[81] Transgenic mouse studies indicate that there is redundancy spread across HOX genes that complicate the issue, and that complex interactions between these genes could play a role in determining whether or not a person inheriting the requisite combinations manifests an autistic spectum condition[82]—transgenic mice with mutations in both HOXA1 and HOXB1 exhibit far more profound developmental anomalies than those in which only one of the genes differs from the conserved 'norm'.

In Rodier's original work, teratogens are considered to play a part in addition, and that the possibility remains open for a range of teratogens to interact with the mechanisms controlled by these genes unfavourably (this has already been demonstrated using valproic acid, a known teratogen, in the mouse model).

PRKCB1 – Philippi et al (2005) found a strong association between this gene and autism. This is a recent finding that needs to be replicated.[83]

FOXP2 – The FOXP2 gene is of interest because it is known to be associated with developmental language and speech deficits. An association to autism appears to be elusive, nonetheless.[84][85]

UBE3A – The UBE3A gene has been associated with Angelman syndrome. Samaco et al (2005) suggest reduced expression of UBE3A in autism, as is the case in Rett syndrome.[86] In any case, it appears that the role of UBE3A is limited.

Shank3/ProSAP2, 22q13 and Neuroligins – The gene called SHANK3 (also designated ProSAP2) regulates the structural organization of neurotransmitter receptors in post-synaptic dendritic spines making it a key element in chemical binding crucial to nerve cell communication.[87] SHANK3 is also a binding partner of chromosome 22q13 (i.e. a specific section of Chromosome 22) and neuroligin proteins; deletions and mutations of SHANK3, 22q13 (i.e. a specific section of Chromosome 22) and genes encoding neuroligins have been found in some people with autism spectrum disorders.[88]

Mutations in the SHANK3 gene have been strongly associated with the autism spectrum disorders. If the SHANK3 gene is not adequately passed to a child from the parent (haploinsufficiency) there will possibly be significant neurological changes that are associated with yet another gene, 22q13, which interacts with SHANK3. Alteration or deletion of either will effect changes in the other.[88]

A deletion of a single copy of a gene on chromosome 22q13 has been correlated with global developmental delay, severely delayed speech or social communication disorders and moderate to profound delay of cognitive abilities. Behavior is described as "autistic-like" and includes high tolerance to pain and habitual chewing or mouthing[88] (see also 22q13 deletion syndrome). This appears to be connected to the fact that signal transmission between nerve cells is altered with the absence of 22q13.

SHANK3 proteins also interact with neuroligins at the synapses of the brain further complicating the widespread effects of changes at the genetic level and beyond.[89]

Neuroligin is a cell surface protein (homologous to acetylcholinesterase and other esterases) that binds to synaptic membranes.[90] Neuroligins organize postsynaptic membranes that function to transmit nerve cell messages (excitatory) and stop those transmissions (inhibitory);[91] In this way, neuroligins help to ensure signal transitions between nerve cells. Neuroligins are also regulate the maturation of synapses and ensure there are sufficient receptor proteins on the synaptic membrane.

Mice with a neuroligin-3 mutation exhibit poor social skills but increased intelligence.[92] Though not present in all individuals with autism, these mutations hold potential to illustrate some of the genetic components of spectrum disorders.[89]

MET – The MET gene (MET receptor tyrosine kinase gene) linked to brain development, regulation of the immune system, and repair of the gastrointestinal system, has been linked to autism. This MET gene codes for a protein that relays signals that turn on a cell’s internal machinery. Impairing the receptor’s signaling interferes with neuron migration and disrupts neuronal growth in the cerebral cortex and similarly shrinks the cerebellum—abnormalities also seen in autism.[93]

It is also known to play a key role in both normal and abnormal development, such as cancer metastases (hence the name MET). A mutation of the gene, rendering it less active, has been found to be common amongst children with autism.[93] Mutation in the MET gene demonstrably raises risk of autism by 2.27 times.[94]

neurexin 1 – In February 2007, researchers in the Autism Genome Project (an international research team composed of 137 scientists in 50 institutions) reported possible implications in aberrations of a brain-development gene called neurexin 1 as a cause of some cases of autism.[95] Linkage analysis was performed on DNA from 1,181 families in what was the largest-scale genome scan conducted in autism research at the time.

The objective of the study was to locate specific brain cells involved in autism to find regions in the genome linked to autism susceptibility genes. The focus of the research was copy number variations (CNVs), extra or missing parts of genes. Each person does not actually have just an exact copy of genes from each parent. Each person also has occasional multiple copies of one or more genes or some genes are missing altogether. The research team attempted to locate CNVs when they scanned the DNA.

Neurexin 1 is one of the genes that may be involved in communication between nerve cells (neurons). Neurexin 1 and other genes like it are very important in determining how the brain is connected from cell to cell, and in the chemical transmission of information between nerve cells. These genes are particularly active very early in brain development, either in utero or in the first months or couple of years of life. In some families their autistic child had only one copy of the neurexin 1 gene.

Besides actually locating yet another possible genetic influence (the findings were statistically insignificant), the research also reinforced the theory that autism involves many forms of genetic variations.

GSTP1 – A 2007 study suggested that the GSTP1*A haplotype of the glutathione S-transferase P1 gene (GSTP1) acts in the mother during pregnancy and increases the likelihood of autism in the child.[96]

Others – There is a large number of other candidate loci which either should be looked at or have been shown to be promising. Several genome-wide scans have been performed identifying markers across many chromosomes.[97][98][99]

A few examples of loci that have been studied are the 17q21 region, the 3p24-26 locus,[97] PTEN,[100] and 15q11-q13.[61]

Other possible candidates include:

  • SLC6A2 (Social phobia)
  • FMR1 (Fragile-X)
  • 5-HT-1Dbeta (OCD)
  • 7q11.23 (William's syndrome, language impairment)
  • 4q34-35, 5q35.2-35.3, 17q25 (Tourette syndrome)
  • 2q24.1-31.1 (Intelligence)
  • 6p25.3-22.3 (Verbal IQ)
  • 22q11.2 (Visio-Spatial IQ)

Prenatal Environment

The risk of autism is associated with several prenatal risk factors. Autism has been linked to birth defect agents acting during the first eight weeks from conception, though these cases are rare. Other potential prenatal environmental factors do not have convincing scientific evidence.

Teratogens

Teratogens are environmental agents that cause birth defects. Some agents that are known to cause other birth defects have also been found to be related to autism risk. These include exposure of the embryo to thalidomide, valproic acid, or misoprostol, or to rubella infection in the mother. These cases are rare.[101] Questions have also been raised whether ethanol (grain alcohol) increases autism risk, as part of fetal alcohol syndrome or alcohol-related birth defects, but current evidence is insufficient to determine whether autism risk is actually elevated with ethanol.[102] All known teratogens appear to act during the first eight weeks from conception, and though this does not exclude the possibility that autism can be initiated or affected later, it is strong evidence that autism arises very early in development.[6] Infection-associated immunological events in early pregnancy may affect neural development more than infections in late pregnancy, not only for autism, but also for other psychiatric disorders of presumed neurodevelopmental origin, notably schizophrenia.[103]

Pesticides

A 2007 study by the California Department of Public Health found that women in the first eight weeks of pregnancy who live near farm fields sprayed with the organochlorine pesticides dicofol and endosulfan are several times more likely to give birth to children with autism. The association appeared to increase with dose and decrease with distance from field site to residence. The study's findings suggest that on the order of 7% of autism cases in the California Central Valley might have been connected to exposure to the insecticides drifting off fields into residential areas. These results are highly preliminary due to the small number of women and children involved and lack of evidence from other studies.[104] It is not known whether these pesticides are human teratogens, though endosulfan has significant teratogenic effects in laboratory rats.[105]

A 2005 study showed indirect evidence that prenatal exposure to organophosphate pesticides such as diazinon and chlorpyrifos may contribute to autism in genetically vulnerable children.[106] Several other studies demonstrate the neurodevelopmental toxicity of these agents at relatively low exposure levels.[107]

Folic acid

Folic acid taken during pregnancy might play an important role in causing autism by modulating gene expression through epigenetic mechanism. This hypothesis is untested.[108]

Fetal Testosterone

The fetal testosterone theory hypothesizes that higher levels of testosterone in the amniotic fluid of mothers pushes brain development towards improved ability to see patterns and analyze complex systems while diminishing communication and empathy, emphasizing "male" traits over "female", or in EQ SQ Theory terminology, emphasizing "systemizing" over "empathizing".[109] One project has published several reports suggesting that high levels of fetal testosterone could produce behaviors relevant to those seen in autism.[110] The theory and findings are controversial and many studies contradict the idea that baby boys and girls respond differently to people and objects.[111]

Ultrasound

A 2006 study found that sustained exposure of mouse embryos to ultrasound waves caused a small but statistically significant number of neurons to fail to acquire their proper position during neuronal migration.[112] It is highly unlikely that this result speaks directly to risks of fetal ultrasound as practiced in competent and responsible medical centers.[113] There is no scientific evidence of an association between prenatal ultrasound exposure and autism, but there are very little data on human fetal exposure during diagnostic ultrasound, and the lack of recent epidemiological research and human data in the field has been called "appalling".[114]

Perinatal Environment

Autism is associated with some perinatal and obstetric conditions. A 2007 review of risk factors found associated obstetric conditions that included low birth weight and gestation duration, and hypoxia during childbirth. This association does not demonstrate a causal relationship; an underlying cause could explain both autism and these associated conditions.[9] A 2007 study of premature infants found that those who survived cerebellar hemorrhagic injury (bleeding in the brain that injures the cerebellum) were significantly more likely to show symptoms of autism than controls without the injury.[115]

Postnatal Environment

A wide variety of postnatal contributors to autism have been proposed, including gastrointestinal or immune system abnormalities, allergies, and exposure of children to drugs, vaccines, infection, certain foods, or heavy metals. The evidence for these risk factors is anecdotal and has not been confirmed by reliable studies.[5] The subject remains controversial and extensive further searches for environmental factors are underway.[101]

Leaky Gut Syndrome

Parents have reported gastrointestinal (GI) disturbances in autistic children, and several studies have investigated possible associations between autism and the gut.[116] The controversial Wakefield et al. vaccine paper discussed in "MMR vaccine" below also suggested that some bowel disorders may allow antigens to pass from food into the bloodstream and then to contribute to brain dysfunction.[117] This produced several lines of investigation.

For example, employing secretin's effects on digestion, a 1998 study of three children with ASD treated with secretin infusion reported improved GI function and dramatic improvement in behavior, which suggested an association between GI and brain function in autistic children.[118] After this study, many parents sought secretin treatment and a black market for the hormone developed quickly.[116] However, later studies found secretin ineffective in treating autism.[119]

Leaky gut syndrome theories also inspired several dietary treatments, including gluten-free diets, casein-free diets, antifungal diets, low-sugar diets, as well as supplements that include nystatin, [[B12|BTemplate:Ssub]], and probiotics. Parents are more likely to get advice about these diets from other parents, the media, and the Internet than from medical experts. There is no solid research evidence that autistic children are more likely to have GI symptoms than typical children.[116] In particular, design flaws in studies of elimination diets mean that the currently available data are inadequate to guide treatment recommendations.[120]

Viral Infection

Many studies have presented evidence for and against association of autism with viral infection after birth. Laboratory rats infected with Borna disease virus show some symptoms similar to those of autism but blood studies of autistic children show no evidence of infection by this virus. Members of the herpes virus family may have a role in autism, but the evidence so far is anecdotal. Viruses have long been suspected as triggers for immune-mediated diseases such as multiple sclerosis but showing a direct role for viral causation is difficult in those diseases, and mechanisms whereby viral infections could lead to autism are speculative.[121]

Oxidative Stress

This theory hypothesizes that toxicity and oxidative stress may cause autism in some cases by damaging Purkinje cells in the cerebellum after birth. One possibility is that glutathione is involved.[122]

Amygdala Neurons

This theory hypothesizes that an early developmental failure involving the amygdala cascades on the development of cortical areas that mediate social perception in the visual domain. The fusiform face area of the ventral stream is implicated. The idea is that it is involved in social knowledge and social cognition, and that the deficits in this network are instrumental in causing autism.[123]

Vitamin D

This theory hypothesizes that autism is caused by vitamin D deficiency, and that recent increases in diagnosed cases of autism are due to medical advice to avoid the sun. The theory has not been studied scientifically.[124]

Lead

Lead poisoning has been suggested as a possible risk factor for autism, as the lead blood levels of autistic children has been reported to be significantly higher than typical. The atypical eating behaviors of autistic children, along with habitual mouthing and pica, make it hard to determine whether increased lead levels are a cause or a consequence of autism.[125]

Mercury and MMR Vaccine

This theory hypothesizes that autism is associated with mercury poisoning, based on perceived similarity of symptoms.[126] The principal source of human exposure to organic mercury is via fish consumption and for inorganic mercury is dental amalgams. Other forms of exposure, such as in cosmetics and vaccines, also occur. The evidence so far is indirect for the association between autism and mercury exposure after birth, as no direct test has been reported, and there is no evidence of an association between autism and postnatal exposure to any neurotoxicant.[127]

A 2003 study reported that mercury measurements of hair samples from autistic children's first haircuts were significantly lower than a matched group of normal children, declining as measures of severity increased,[128] but a later meta-analysis based on two studies found that there was not enough evidence to conclude that hair mercury level is lower in autistic children.[129] A 2006 study found an association between autism and environmental releases of mercury, primarily from coal power plants; this study used Texas county-wide data and did not distinguish between prenatal and postnatal exposure.[130]

Although parents may first become aware of autistic symptoms in their child around the time of a routine vaccination, and parental concern about vaccines has led to a decreasing uptake of childhood immunizations and an increasing likelihood of measles outbreaks, there is overwhelming scientific evidence showing no causal association between the measles-mumps-rubella vaccine and autism, and there is no scientific evidence that the vaccine preservative thiomersal helps cause autism.[131]

Television Watching

Three economists hypothesized that early childhood television viewing acts as an environmental trigger for an underlying genetic predisposition. They found that precipitation was associated with autism by examining county-level autism data for California, Oregon, and Washington. Precipitation is also associated with television watching, and their analysis concluded that just under 40% of autism diagnoses in the three states result from television watching due to precipitation.[132] This study has not been published in a refereed journal and its results have not been confirmed by others.

Refrigerator Mother

Bruno Bettelheim believed that autism was linked to early childhood trauma, and his work was highly influential for decades both in the medical and popular spheres. Parents, especially mothers, of individuals with autism were blamed for having caused their child's condition through the withholding of affection.[133] Leo Kanner, who first described autism,[134] suggested that parental coldness might contribute to autism.[135] Although Kanner eventually renounced the theory, Bettelheim put an almost exclusive emphasis on it in both his medical and his popular books. Treatments based on these theories failed to help children with autism, and after Bettelheim's death it came out that his reported rates of cure (around 85%) were found to be fraudulent.[136]

Other Psychogenic Theories

Psychogenic theories in general have become increasingly unpopular, particularly since twin studies have shown that autism is highly heritable. Nevertheless, some case reports have found that deep institutional privation can result in "quasi-autistic" features without the neuroanatomical differences.[137][138] Other case reports have suggested that children predisposed genetically to autism can develop "autistic devices" in response to traumatic events such as the birth of a sibling.[139]

References

  1. 1.0 1.1 1.2 Freitag CM (2007). "The genetics of autistic disorders and its clinical relevance: a review of the literature". Mol Psychiatry. 12 (1): 2–22. doi:10.1038/sj.mp.4001896. PMID 17033636.
  2. 2.0 2.1 Sykes NH, Lamb JA (2007). "Autism: the quest for the genes". Expert Rev Mol Med. 9 (24): 1–15. doi:10.1017/S1462399407000452. PMID 17764594.
  3. Folstein SE, Rosen-Sheidley B (2001). "Genetics of autism: complex aetiology for a heterogeneous disorder". Nat Rev Genet. 2 (12): 943–55. doi:10.1038/35103559. PMID 11733747.
  4. 4.0 4.1 Trottier G, Srivastava L, Walker CD (1999). "Etiology of infantile autism: a review of recent advances in genetic and neurobiological research". J Psychiatry Neurosci. 24 (2): 103–115. PMID 10212552. Retrieved 2007-07-16.
  5. 5.0 5.1 Rutter M (2005). "Incidence of autism spectrum disorders: changes over time and their meaning". Acta Paediatr. 94 (1): 2–15. PMID 15858952.
  6. 6.0 6.1 Arndt TL, Stodgell CJ, Rodier PM (2005). "The teratology of autism". Int J Dev Neurosci. 23 (2–3): 189–99. doi:10.1016/j.ijdevneu.2004.11.001. PMID 15749245.
  7. 7.0 7.1 Beaudet AL (2007). "Autism: highly heritable but not inherited". Nat Med. 13 (5): 534–6. doi:10.1038/nm0507-534. PMID 17479094.
  8. Sebat J, Lakshmi B, Malhotra D; et al. (2007). "Strong association of de novo copy number mutations with autism". Science. 316 (5823): 445–9. doi:10.1126/science.1138659. PMID 17363630.
  9. 9.0 9.1 Kolevzon A, Gross R, Reichenberg A (2007). "Prenatal and perinatal risk factors for autism". Arch Pediatr Adolesc Med. 161 (4): 326–33. PMID 17404128.
  10. Persico AM, Bourgeron T (2006). "Searching for ways out of the autism maze: genetic, epigenetic and environmental clues". Trends Neurosci. 29 (7): 349–58. doi:10.1016/j.tins.2006.05.010. PMID 16808981.
  11. SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3
  12. Gene linked to autism discovered
  13. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
  14. WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B; WNT7B
  15. Twin studies (concordance in brackets):
    • (0.6–0.92) Muhle R, Trentacoste SV, Rapin I (2004). "The genetics of autism". Pediatrics. 113 (5): e472–86. PMID 15121991.
    • (0.6–0.8) Kurita H (2001). "[Current status of autism studies]". Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica (in Japanese). 103 (1): 64–75. PMID 11383012.
  16. Folstein SE, Rosen-Sheidley B (2001). "Genetics of autism: complex aetiology for a heterogeneous disorder". Nat Rev Genet. 2 (12): 943–55. doi:10.1038/35103559. PMID 11733747.
  17. Muhle R, Trentacoste SV, Rapin I (2004). "The genetics of autism". Pediatrics. 113 (5): e472–86. PMID 15121991.
  18. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ (2005). "Genetic influences in irritable bowel syndrome: a twin study". Am. J. Gastroenterol. 100 (6): 1340–4. doi:10.1111/j.1572-0241.2005.41700.x. PMID 15929767.
  19. Bito LZ, Matheny A, Cruickshanks KJ, Nondahl DM, Carino OB (1997). "Eye color changes past early childhood. The Louisville Twin Study". Arch. Ophthalmol. 115 (5): 659–63. PMID 9152135.
  20. Folstein S, Rutter M (1977). "Infantile autism: a genetic study of 21 twin pairs". Journal of child psychology and psychiatry, and allied disciplines. 18 (4): 297–321. PMID 562353.
  21. Wessels WH, Pompe van Meerdervoort M (1979). "Monozygotic twins with early infantile autism. A case report". S. Afr. Med. J. 55 (23): 955–7. PMID 572995.
  22. 22.0 22.1 Ritvo ER, Freeman BJ, Mason-Brothers A, Mo A, Ritvo AM (1985). "Concordance for the syndrome of autism in 40 pairs of afflicted twins". The American journal of psychiatry. 142 (1): 74–7. PMID 4038442.
  23. Steffenburg S, Gillberg C, Hellgren L; et al. (1989). "A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden". Journal of child psychology and psychiatry, and allied disciplines. 30 (3): 405–16. PMID 2745591.
  24. Bailey A, Le Couteur A, Gottesman I; et al. (1995). "Autism as a strongly genetic disorder: evidence from a British twin study". Psychological medicine. 25 (1): 63–77. PMID 7792363.
  25. Scourfield J, Martin N, Lewis G, McGuffin P (1999). "Heritability of social cognitive skills in children and adolescents". The British journal of psychiatry : the journal of mental science. 175: 559–64. PMID 10789354.
  26. Constantino JN, Todd RD (2000). "Genetic structure of reciprocal social behavior". The American journal of psychiatry. 157 (12): 2043–5. PMID 11097975.
  27. Kates WR, Burnette CP, Eliez S; et al. (2004). "Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism". The American journal of psychiatry. 161 (3): 539–46. PMID 14992981.
  28. Kolevzon A, Smith CJ, Schmeidler J, Buxbaum JD, Silverman JM (2004). "Familial symptom domains in monozygotic siblings with autism". Am. J. Med. Genet. B Neuropsychiatr. Genet. 129 (1): 76–81. doi:10.1002/ajmg.b.30011. PMID 15274045.
  29. Ronald A, Happé F, Bolton P; et al. (2006). "Genetic heterogeneity between the three components of the autism spectrum: a twin study". Journal of the American Academy of Child and Adolescent Psychiatry. 45 (6): 691–9. doi:10.1097/01.chi.0000215325.13058.9d. PMID 16721319.
  30. Joseph J (2006). "Autism and genetics: much ado about very little". The Missing Gene: Psychiatry, Heredity, and the Fruitless Search for Genes. Algora. ISBN 0875864104. Retrieved 2007-07-25.
  31. 31.0 31.1 Bolton P, Macdonald H, Pickles A; et al. (1994). "A case-control family history study of autism". Journal of child psychology and psychiatry, and allied disciplines. 35 (5): 877–900. PMID 7962246.
  32. Hughes C, Plumet MH, Leboyer M (1999). "Towards a cognitive phenotype for autism: increased prevalence of executive dysfunction and superior spatial span amongst siblings of children with autism". Journal of child psychology and psychiatry, and allied disciplines. 40 (5): 705–18. PMID 10433405.
  33. Lauritsen MB, Pedersen CB, Mortensen PB (2005). "Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study". Journal of child psychology and psychiatry, and allied disciplines. 46 (9): 963–71. doi:10.1111/j.1469-7610.2004.00391.x. PMID 16108999.
  34. 34.0 34.1 Zhao X, Leotta A, Kustanovich V; et al. (2007). "A unified genetic theory for sporadic and inherited autism". Proc. Natl. Acad. Sci. U.S.A. 104 (31): 12831–6. doi:10.1073/pnas.0705803104. PMID 17652511. Lay summaryCSHL (2007-07-23).
  35. Piven J, Wzorek M, Landa R; et al. (1994). "Personality characteristics of the parents of autistic individuals". Psychological medicine. 24 (3): 783–95. PMID 7991760.
  36. Piven J, Palmer P, Jacobi D, Childress D, Arndt S (1997). "Broader autism phenotype: evidence from a family history study of multiple-incidence autism families". The American journal of psychiatry. 154 (2): 185–90. PMID 9016266.
  37. Baron-Cohen S, Wheelwright S, Stott C, et al. "Is there a link between engineering and autism?" (PDF) Autism, 1997, 1, 153-163. Retrieved December 10, 2006.
  38. Wheelwright S, Baron-Cohen S (2001). "The link between autism and skills such as engineering, maths, physics and computing: a reply to Jarrold and Routh". Autism : the international journal of research and practice. 5 (2): 223–7. PMID 11706868.Online.
  39. Silberman, Steve. The Geek Syndrome. Wired Magazine (December 2001). Retrieved on December 10, 2006.
  40. Happé F, Briskman J, Frith U (2001). "Exploring the cognitive phenotype of autism: weak "central coherence" in parents and siblings of children with autism: I. Experimental tests". Journal of child psychology and psychiatry, and allied disciplines. 42 (3): 299–307. PMID 11321199.
  41. Abramson RK, Ravan SA, Wright HH; et al. (2005). "The relationship between restrictive and repetitive behaviors in individuals with autism and obsessive compulsive symptoms in parents". Child psychiatry and human development. 36 (2): 155–65. doi:10.1007/s10578-005-2973-7. PMID 16228144.
  42. Constantino JN, Todd RD (2005). "Intergenerational transmission of subthreshold autistic traits in the general population". Biol. Psychiatry. 57 (6): 655–60. doi:10.1016/j.biopsych.2004.12.014. PMID 15780853.
  43. Ghaziuddin M (2005). "A family history study of Asperger syndrome". Journal of autism and developmental disorders. 35 (2): 177–82. PMID 15909404.
  44. Greenberg DA, Hodge SE, Sowinski J, Nicoll D (2001). "Excess of twins among affected sibling pairs with autism: implications for the etiology of autism". Am. J. Hum. Genet. 69 (5): 1062–7. PMID 11590546.
  45. Hallmayer J, Glasson EJ, Bower C; et al. (2002). "On the twin risk in autism". Am. J. Hum. Genet. 71 (4): 941–6. PMID 12297988.
  46. Freitag CM (2007). "The genetics of autistic disorders and its clinical relevance: a review of the literature". Mol Psychiatry. 12 (1): 2–22. doi:10.1038/sj.mp.4001896. PMID 17033636. Retrieved 2007-07-18.
  47. Hobson RP, Lee A, Brown R (1999). "Autism and congenital blindness". Journal of autism and developmental disorders. 29 (1): 45–56. PMID 10097994.
  48. Hoksbergen R, ter Laak J, Rijk K, van Dijkum C, Stoutjesdijk F (2005). "Post-Institutional Autistic Syndrome in Romanian adoptees". Journal of autism and developmental disorders. 35 (5): 615–23. doi:10.1007/s10803-005-0005-x. PMID 16167089.
  49. Rutter ML, Kreppner JM, O'Connor TG (2001). "Specificity and heterogeneity in children's responses to profound institutional privation". The British journal of psychiatry : the journal of mental science. 179: 97–103. PMID 11483469.
  50. Rutter M, Bailey A, Bolton P, Le Couteur A (1994). "Autism and known medical conditions: myth and substance". Journal of child psychology and psychiatry, and allied disciplines. 35 (2): 311–22. PMID 8188801.
  51. Pickles A, Bolton P, Macdonald H; et al. (1995). "Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism". Am. J. Hum. Genet. 57 (3): 717–26. PMID 7668301.
  52. Risch N, Spiker D, Lotspeich L; et al. (1999). "A genomic screen of autism: evidence for a multilocus etiology". Am. J. Hum. Genet. 65 (2): 493–507. PMID 10417292.
  53. Jiang YH, Sahoo T, Michaelis RC; et al. (2004). "A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A". Am. J. Med. Genet. A. 131 (1): 1–10. doi:10.1002/ajmg.a.30297. PMID 15389703.
  54. Skuse DH (2000). "Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism". Pediatr. Res. 47 (1): 9–16. PMID 10625077.
  55. Schanen NC (2006). "Epigenetics of autism spectrum disorders". Hum Mol Genet. 15 (Review 2): R138–50. doi:10.1093/hmg/ddl213. PMID 16987877.
  56. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J (2006). "Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder". Biol. Psychiatry. 59 (3): 224–9. doi:10.1016/j.biopsych.2005.07.014. PMID 16154545.
  57. Sutcliffe JS, Delahanty RJ, Prasad HC; et al. (2005). "Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors". Am. J. Hum. Genet. 77 (2): 265–79. doi:10.1086/432648. PMID 15995945.
  58. Devlin B, Cook EH, Coon H; et al. (2005). "Autism and the serotonin transporter: the long and short of it". Mol. Psychiatry. 10 (12): 1110–6. doi:10.1038/sj.mp.4001724. PMID 16103890.
  59. Coutinho AM, Oliveira G, Morgadinho T; et al. (2004). "Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism". Mol. Psychiatry. 9 (3): 264–71. doi:10.1038/sj.mp.4001409. PMID 15094787.
  60. Ma DQ, Whitehead PL, Menold MM; et al. (2005). "Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism". Am. J. Hum. Genet. 77 (3): 377–88. doi:10.1086/433195. PMID 16080114.
  61. 61.0 61.1 Nurmi EL, Dowd M, Tadevosyan-Leyfer O, Haines JL, Folstein SE, Sutcliffe JS (2003). "Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-q13". Journal of the American Academy of Child and Adolescent Psychiatry. 42 (7): 856–63. doi:10.1097/01.CHI.0000046868.56865.0F. PMID 12819446.
  62. Delorey TM, Sahbaie P, Hashemi E, Homanics GE, Clark JD (2007). "Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: A potential model of autism spectrum disorder". Behav Brain Res. doi:10.1016/j.bbr.2007.09.009. PMID 17983671.
  63. Benayed R, Gharani N, Rossman I; et al. (2005). "Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus". Am. J. Hum. Genet. 77 (5): 851–68. doi:10.1086/497705. PMID 16252243.
  64. Zhong H, Serajee FJ, Nabi R, Huq AH (2003). "No association between the EN2 gene and autistic disorder". J. Med. Genet. 40 (1): e4. PMID 12525552.
  65. Auranen M, Varilo T, Alen R; et al. (2003). "Evidence for allelic association on chromosome 3q25-27 in families with autism spectrum disorders originating from a subisolate of Finland". Mol. Psychiatry. 8 (10): 879–84. doi:10.1038/sj.mp.4001299. PMID 14515138.
  66. Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E; et al. (2004). "Genome-wide scan for loci of Asperger syndrome". Mol. Psychiatry. 9 (2): 161–8. doi:10.1038/sj.mp.4001385. PMID 14966474.
  67. Auranen M, Vanhala R, Varilo T; et al. (2002). "A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27". Am. J. Hum. Genet. 71 (4): 777–90. PMID 12192642.
  68. Serajee FJ, Zhong H, Mahbubul Huq AH (2006). "Association of Reelin gene polymorphisms with autism". Genomics. 87 (1): 75–83. doi:10.1016/j.ygeno.2005.09.008. PMID 16311013.
  69. Skaar DA, Shao Y, Haines JL; et al. (2005). "Analysis of the RELN gene as a genetic risk factor for autism". Mol. Psychiatry. 10 (6): 563–71. doi:10.1038/sj.mp.4001614. PMID 15558079.
  70. Li J, Nguyen L, Gleason C; et al. (2004). "Lack of evidence for an association between WNT2 and RELN polymorphisms and autism". Am. J. Med. Genet. B Neuropsychiatr. Genet. 126 (1): 51–7. doi:10.1002/ajmg.b.20122. PMID 15048648.
  71. Segurado R, Conroy J, Meally E, Fitzgerald M, Gill M, Gallagher L (2005). "Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31". The American journal of psychiatry. 162 (11): 2182–4. doi:10.1176/appi.ajp.162.11.2182. PMID 16263864.
  72. Ramoz N, Reichert JG, Smith CJ; et al. (2004). "Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism". The American journal of psychiatry. 161 (4): 662–9. PMID 15056512.
  73. Blasi F, Bacchelli E, Carone S; et al. (2006). "SLC25A12 and CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family sample". Eur. J. Hum. Genet. 14 (1): 123–6. doi:10.1038/sj.ejhg.5201444. PMID 16205742.
  74. Kent L, Gallagher L, Elliot HR, Mowbray C, Chinnery PF (2007). "An investigation of mitochondrial haplogroups in autism". Am J Med Genet B Neuropsychiatr Genet. doi:10.1002/ajmg.b.30687. PMID 18161860.
  75. Rodier PM (2000). "The early origins of autism". Sci. Am. 282 (2): 56–63. PMID 10710787.
  76. Conciatori M, Stodgell CJ, Hyman SL; et al. (2004). "Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism". Biol. Psychiatry. 55 (4): 413–9. doi:10.1016/j.biopsych.2003.10.005. PMID 14960295.
  77. Gallagher L, Hawi Z, Kearney G, Fitzgerald M, Gill M (2004). "No association between allelic variants of HOXA1/HOXB1 and autism". Am. J. Med. Genet. B Neuropsychiatr. Genet. 124 (1): 64–7. doi:10.1002/ajmg.b.20094. PMID 14681917.
  78. Collins JS, Schroer RJ, Bird J, Michaelis RC (2003). "The HOXA1 A218G polymorphism and autism: lack of association in white and black patients from the South Carolina Autism Project". Journal of autism and developmental disorders. 33 (3): 343–8. PMID 12908836.
  79. Talebizadeh Z, Bittel DC, Miles JH; et al. (2002). "No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD)". J. Med. Genet. 39 (11): e70. PMID 12414832.
  80. Tischfield MA, Bosley TM, Salih MA; et al. (2005). "Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development". Nat. Genet. 37 (10): 1035–7. doi:10.1038/ng1636. PMID 16155570.
  81. Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM (2000). "Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders". Teratology. 62 (6): 393–405. doi:10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.0.CO;2-V. PMID 11091361.
  82. Rossel M, Capecchi MR (1999). "Mice mutant for both Hoxa1 and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development". Development. 126 (22): 5027–40. PMID 10529420.
  83. Philippi A, Roschmann E, Tores F; et al. (2005). "Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism". Mol. Psychiatry. 10 (10): 950–60. doi:10.1038/sj.mp.4001704. PMID 16027742.
  84. Marui T, Koishi S, Funatogawa I; et al. (2005). "No association of FOXP2 and PTPRZ1 on 7q31 with autism from the Japanese population". Neurosci. Res. 53 (1): 91–4. doi:10.1016/j.neures.2005.05.003. PMID 15998549.
  85. Gauthier J, Joober R, Mottron L; et al. (2003). "Mutation screening of FOXP2 in individuals diagnosed with autistic disorder". Am. J. Med. Genet. A. 118 (2): 172–5. doi:10.1002/ajmg.a.10105. PMID 12655497.
  86. Samaco RC, Hogart A, LaSalle JM (2005). "Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3". Hum. Mol. Genet. 14 (4): 483–92. doi:10.1093/hmg/ddi045. PMID 15615769.
  87. Schuetz G, Rosário M, Grimm J, Boeckers TM, Gundelfinger ED, Birchmeier W (2004). "The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells". J. Cell Biol. 167 (5): 945–52. doi:10.1083/jcb.200404108. PMID 15569713.
  88. 88.0 88.1 88.2 Deletion 22q13 Syndrome M.C Phelan (2003) Orphanet.com
  89. 89.0 89.1 Durand CM, Betancur C, Boeckers TM; et al. (2007). "Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders". Nat. Genet. 39 (1): 25–7. doi:10.1038/ng1933. PMID 17173049. Lay summaryAutism Speaks. |access-date= requires |url= (help)
  90. Neuroligins Kristen Harris (2001) Cell adhesion at synapses Synapse Web, Laboratory of Synapse Structure and Function. Human Brain Project. National Institute of Mental Health and the National Institute of Drug Abuse
  91. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM (2004). "Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins". Cell. 119 (7): 1013–26. doi:10.1016/j.cell.2004.11.035. PMID 15620359.
  92. Tabuchi K, Blundell J, Etherton MR; et al. (2007). "A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice". Science. 318 (5847): 71–6. doi:10.1126/science.1146221. PMID 17823315. Lay summaryScience Daily (2007-09-08).
  93. 93.0 93.1 Gene Linked to Autism in Families with More Than One Affected Child National Institutes of Health News (2006) Retrieved March 3, 2007
  94. Campbell DB, Sutcliffe JS, Ebert PJ; et al. (2006). "A genetic variant that disrupts MET transcription is associated with autism". Proc. Natl. Acad. Sci. U.S.A. 103 (45): 16834–9. doi:10.1073/pnas.0605296103. PMID 17053076. Lay summaryBBC News (2006-10-28).
  95. Autism Genome Project Consortium (2007). "Mapping autism risk loci using genetic linkage and chromosomal rearrangements". Nat Genet. 39 (3): 319–28. doi:10.1038/ng1985. PMID 17322880. Lay summaryPress release (2007-02-18). Corrigendum (2007). Nat Genet 39 (10): 1285. doi:10.1038/ng1007-1285a. PMID 17898782.
  96. Williams TA, Mars AE, Buyske SG; et al. (2007). "Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype". Archives of pediatrics & adolescent medicine. 161 (4): 356–61. doi:10.1001/archpedi.161.4.356. PMID 17404132.
  97. 97.0 97.1 Ylisaukko-oja T, Alarcón M, Cantor RM; et al. (2006). "Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families". Ann. Neurol. 59 (1): 145–55. doi:10.1002/ana.20722. PMID 16288458.
  98. Lauritsen MB, Als TD, Dahl HA; et al. (2006). "A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands". Mol. Psychiatry. 11 (1): 37–46. doi:10.1038/sj.mp.4001754. PMID 16205737.
  99. Trikalinos TA, Karvouni A, Zintzaras E; et al. (2006). "A heterogeneity-based genome search meta-analysis for autism-spectrum disorders". Mol. Psychiatry. 11 (1): 29–36. doi:10.1038/sj.mp.4001750. PMID 16189507.
  100. Butler MG, Dasouki MJ, Zhou XP; et al. (2005). "Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations". J. Med. Genet. 42 (4): 318–21. doi:10.1136/jmg.2004.024646. PMID 15805158.
  101. 101.0 101.1 Szpir M (2006). "Tracing the origins of autism: a spectrum of new studies". Environ Health Perspect. 114 (7): A412–8. PMID 16835042.
  102. Fombonne E (2002). "Is exposure to alcohol during pregnancy a risk factor for autism?". J Autism Dev Disord. 32 (3): 243. doi:10.1023/A:1015466100838. PMID 12108626.
  103. Meyer U, Yee BK, Feldon J (2007). "The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?". Neuroscientist. 13 (3): 241–56. doi:10.1177/1073858406296401. PMID 17519367.
  104. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C (2007). "Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley". Environ Health Perspect. 115 (10): 1482–9. doi:10.1289/ehp.10168. PMID 17938740. Lay summaryEHP (2007).
  105. Singh ND, Sharma AK, Dwivedi P, Patil RD, Kumar M (2007). "Citrinin and endosulfan induced teratogenic effects in Wistar rats". J Appl Toxicol. 27 (2): 143–51. doi:10.1002/jat.1185. PMID 17186572.
  106. D'Amelio M, Ricci I, Sacco R; et al. (2005). "Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions". Mol Psychiatry. 10 (11): 1006–16. doi:10.1038/sj.mp.4001714. PMID 16027737.
  107. Karr CJ, Solomon GM, Brock-Utne AC (2007). "Health effects of common home, lawn, and garden pesticides". Pediatr Clin North Am. 54 (1): 63–80. doi:10.1016/j.pcl.2006.11.005. PMID 17306684.
  108. Muskiet FA, Kemperman RF (2006). "Folate and long-chain polyunsaturated fatty acids in psychiatric disease". J Nutr Biochem. 17 (11): 717–27. doi:10.1016/j.jnutbio.2006.02.001. PMID 16650750.
  109. Baron-Cohen S (2004). The Essential Difference: Male and Female Brains and the Truth About Autism. Basic Books. ISBN 046500556X.
  110. Fetal testosterone studies:
  111. Rivers C (2006-09-28). "Discrimination against the female brain". AlterNet. Retrieved 2006-12-10.
  112. Ang ES Jr, Gluncic V, Duque A, Schafer ME, Rakic P (2006). "Prenatal exposure to ultrasound waves impacts neuronal migration in mice". Proc Natl Acad Sci U S A. 103 (34): 12903–10. doi:10.1073/pnas.0605294103. PMID 16901978.
  113. Caviness VS, Grant PE (2006). "Our unborn children at risk?". Proc Natl Acad Sci U S A. 103 (34): 12661–2. doi:10.1073/pnas.0605505103.
  114. Abramowicz JS (2007). "Prenatal exposure to ultrasound waves: is there a risk?". Ultrasound Obstet Gynecol. 29 (4): 363–7. doi:10.1002/uog.3983. PMID 17352453.
  115. Limperopoulos C, Bassan H, Gauvreau K; et al. (2007). "Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors?". Pediatrics. 120 (3): 584–93. doi:10.1542/peds.2007-1041. PMID 17766532.
  116. 116.0 116.1 116.2 Johnson TW (2006). "Dietary considerations in autism: identifying a reasonable approach". Top Clin Nutr. 21 (3): 212–25.
  117. Wakefield A, Murch S, Anthony A; et al. (1998). "Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". Lancet. 351 (9103): 637–41. doi:10.1016/S0140-6736(97)11096-0. PMID 9500320. Retrieved 2007-09-05.
  118. Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT (1998). "Improved social and language skills after secretin administration in patients with autistic spectrum disorders". J Assoc Acad Minor Phys. 9 (1): 9–15. PMID 9585670.
  119. Sturmey P (2005). "Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials". Res Dev Disabil. 26 (1): 87–97. PMID 15590241.
  120. Christison GW, Ivany K (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr. 27 (2 Suppl 2): S162–71. PMID 16685183.
  121. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS (2005). "Autistic disorder and viral infections". J Neurovirol. 11 (1): 1–10. doi:10.1080/13550280590900553. PMID 15804954.
  122. Kern JK, Jones AM (2006). "Evidence of toxicity, oxidative stress, and neuronal insult in autism". J Toxicol Environ Health B Crit Rev. 9 (6): 485–99. doi:10.1080/10937400600882079. PMID 17090484.
  123. Schultz RT (2005). "Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area". Int J Dev Neurosci. 23 (2–3): 125–41. doi:10.1016/j.ijdevneu.2004.12.012. PMID 15749240.
  124. Cannell JJ (2007). "Autsim and vitamin D". Med Hypotheses. PMID 17920208.
  125. Zafeiriou DI, Ververi A, Vargiami E (2007). "Childhood autism and associated comorbidities". Brain Dev. 29 (5): 257–72. doi:10.1016/j.braindev.2006.09.003. PMID 17084999.
  126. Bernard S, Enayati A, Redwood L, Roger H, Binstock T (2001). "Autism: a novel form of mercury poisoning". Med Hypotheses. 56 (4): 462–71. doi:10.1054/mehy.2000.1281. PMID 11339848.
  127. Davidson PW, Myers GJ, Weiss B (2004). "Mercury exposure and child development outcomes". Pediatrics. 113 (4 Suppl): 1023–9. PMID 15060195.
  128. Holmes AS, Blaxill MF, Haley BE (2003). "Reduced levels of mercury in first baby haircuts of autistic children". Int J Toxicol. 22 (4): 277–85. PMID 12933322.
  129. Ng DK, Chan CH, Soo MT, Lee RS (2007). "Low-level chronic mercury exposure in children and adolescents: meta-analysis". Pediatr Int. 49 (1): 80–7. doi:10.1111/j.1442-200X.2007.02303.x. PMID 17250511.
  130. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C (2006). "Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas". Health Place. 12 (2): 203–9. doi:10.1016/j.healthplace.2004.11.005. PMID 16338635.
  131. Vaccines and autism:
    • Doja A, Roberts W (2006). "Immunizations and autism: a review of the literature". Can J Neurol Sci. 33 (4): 341–6. PMID 17168158.
    • Taylor B (2006). "Vaccines and the changing epidemiology of autism". Child Care Health Dev. 32 (5): 511–9. doi:10.1111/j.1365-2214.2006.00655.x. PMID 16919130.
  132. Template:Cite paper
  133. Bettelheim B (1967). The Empty Fortress: Infantile Autism and the Birth of the Self. Free Press. ISBN 0029031400.
  134. Kanner L (1943). "Autistic disturbances of affective contact". Nerv Child. 2: 217–50. Reprint (1968) Acta Paedopsychiatr 35 (4): 100–36. PMID 4880460.
  135. Kanner L (1949). "Problems of nosology and psychodynamics in early childhood autism". Am J Orthopsychiatry. 19 (3): 416–26. PMID 18146742.
  136. Gardner M (2000). "The brutality of Dr. Bettelheim". Skeptical Inquirer. 24 (6): 12–4.
  137. Rutter ML, Kreppner JM, O'Connor TG, English and Romanian Adoptees (ERA) study team (2001). "Specificity and heterogeneity in children's responses to profound institutional privation". Br J Psychiatry. 179 (2): 97–103. PMID 11483469.
  138. Hoksbergen R, ter Laak J, Rijk K, van Dijkum C, Stoutjesdijk F (2005). "Post-Institutional Autistic Syndrome in Romanian adoptees". J Autism Dev Disord. 35 (5): 615–23. doi:10.1007/s10803-005-0005-x. PMID 16167089.
  139. Gomberoff M, De Gomberoff LP (2000). "Autistic devices in small children in mourning". Int J Psychoanal. 81 (5): 907–20. PMID 11109576.

Template:WH Template:WS